drug

CTX-471

updated 3mo ago

by $COMP Compass, Inc.

community read0 votes

🐶 often sniffed alongside

top 2

all catalysts(1)

phase 1 2 initiation · 1

Compass Therapeutics Inc — CTX-471 (Phase I/II Trial Initiation)

CTX-471

→

Trials studying CTX-471

phase1Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignanciescompletedn=100
phase2Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastomanot yet recruitingn=54

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 16m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

CTX-471

updated 3mo ago

by $COMP Compass, Inc.

community read0 votes

🐶 often sniffed alongside

top 2

all catalysts(1)

phase 1 2 initiation · 1

Compass Therapeutics Inc — CTX-471 (Phase I/II Trial Initiation)

CTX-471

→

Trials studying CTX-471

phase1Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignanciescompletedn=100
phase2Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastomanot yet recruitingn=54

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 16m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

CTX-471

🐶 often sniffed alongside

all catalysts(1)

Trials studying CTX-471

News(0)

Report a data issue

comments(0)

CTX-471

🐶 often sniffed alongside

all catalysts(1)

Trials studying CTX-471

News(0)

Report a data issue

comments(0)